EMA Requests Immediate Recall of MS Drug Daclizumab (Zinbryta - Medscape

Medscape

EMA Requests Immediate Recall of MS Drug Daclizumab (Zinbryta Medscape Today, the European Medicines Agency (EMA) recommended the immediate suspension and recall of the multiple sclerosis (MS) drug daclizumab (Zinbryta, Biogen/AbbVie), following 12 reports of serious inflammatory brain disorders worldwide, including ... EMA suspends, recalls AbbVie and Biogen's doomed MS drug ZinbrytaFiercePharma Biogen, AbbVie's Zinbryta, yanked from market, connected to three US cases of brain inflammationMarketWatch all 5 news articles »

from Health - Google News http://ift.tt/2Fpw3Dd